These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25817775)

  • 21. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
    Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
    J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydropyridines: evaluation of their current and future pharmacological applications.
    Edraki N; Mehdipour AR; Khoshneviszadeh M; Miri R
    Drug Discov Today; 2009 Nov; 14(21-22):1058-66. PubMed ID: 19729074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
    J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines.
    Zamponi GW; Stotz SC; Staples RJ; Andro TM; Nelson JK; Hulubei V; Blumenfeld A; Natale NR
    J Med Chem; 2003 Jan; 46(1):87-96. PubMed ID: 12502362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antioxidant activity of new lipophilic dihydropyridines.
    da Costa Cabrera D; Santa-Helena E; Leal HP; de Moura RR; Nery LEM; Gonçalves CAN; Russowsky D; Montes D'Oca MG
    Bioorg Chem; 2019 Mar; 84():1-16. PubMed ID: 30471487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric 4-aryl-1,4-dihydropyridines potentiate mutant cystic fibrosis transmembrane conductance regulator (CFTR).
    Giampieri M; Vanthuyne N; Nieddu E; Mazzei MT; Anzaldi M; Pedemonte N; Galietta LJ; Roussel C; Mazzei M
    ChemMedChem; 2012 Oct; 7(10):1799-807. PubMed ID: 22927224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of 4-thiophen-2'-yl-1,4-dihydropyridines as potentiators of the CFTR chloride channel.
    Cateni F; Zacchigna M; Pedemonte N; Galietta LJ; Mazzei MT; Fossa P; Giampieri M; Mazzei M
    Bioorg Med Chem; 2009 Dec; 17(23):7894-903. PubMed ID: 19880323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, solvent free synthesis, and antimicrobial evaluation of 1,4 dihydropyridines.
    Murthy YL; Rajack A; Moturu TR; Jeson babu J; Praveen Ch; Aruna Lakshmi K
    Bioorg Med Chem Lett; 2012 Sep; 22(18):6016-23. PubMed ID: 22901391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular simulations study of novel 1,4-dihydropyridines derivatives with a high selectivity for Cav3.1 calcium channel.
    Liu X; Yu H; Zhao X; Huang XR
    Protein Sci; 2015 Nov; 24(11):1737-47. PubMed ID: 26256672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
    Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
    Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes.
    Kumar R; Yadav N; Lavilla R; Blasi D; Quintana J; Brea JM; Loza MI; Mestres J; Bhandari M; Arora R; Kakkar R; Prasad AK
    Mol Divers; 2017 Aug; 21(3):533-546. PubMed ID: 28444482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
    Valasani KR; Chaney MO; Day VW; Shidu Yan S
    J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 1,4-dihydropyridine derivatives on cell injury and mTOR of HepG2 and 3D-QSAR study.
    Liu H; Zhu S; Xia G; Huang Z; Han W; Li Z; Liu C
    Comput Biol Chem; 2024 Apr; 109():108010. PubMed ID: 38232515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.